These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6808384)

  • 1. [Absolute bioavailability of digoxin. Comparison of a soft gelatin capsule with a commercial silicic acid matrix preparation].
    Rietbrock N; Brecht HM; Rudorf JE; Alken RG
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):550-2. PubMed ID: 6808384
    [No Abstract]   [Full Text] [Related]  

  • 2. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of a solution of digoxin in a soft gelatin capsule].
    Marzo A; Ghirardi P; Merotti GC; Gandolfi C
    Boll Soc Ital Cardiol; 1976; 21(10):1781-5. PubMed ID: 1031602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biologic availability of digoxin in soft gelatin capsules and in tablets].
    Merotti GC; Ghirardi P; Marzo A; Parenti MA
    Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1612-4. PubMed ID: 4458749
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability and effect on myocardial function of a solution of digoxin in a soft gelatin capsule].
    Longhini C; Alvisi V; Bagni B; Tralli M; Portaluppi F; Pavani F; Fersini C
    Boll Soc Ital Cardiol; 1976; 21(10):1753-63. PubMed ID: 1031600
    [No Abstract]   [Full Text] [Related]  

  • 8. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 11. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
    Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of digoxin administered in soft gelatin capsules and tablets and evaluated by both radioimmunoassay and enzyme immunoassay.
    Nicaise J; Molron D; Gandolfi C; Ghirardi P; Marzo A
    Farmaco Prat; 1981 Jul; 36(7):341-6. PubMed ID: 7023968
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD; Schmid J; Long RA; Hull JH
    J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses.
    Lloyd BL; Greenblatt DJ; Allen MD; Harmatz JS; Smith TW
    Am J Cardiol; 1978 Jul; 42(1):129-36. PubMed ID: 677028
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bioavailability of Dilanacin and Dilanacin new].
    Sorger D; Gruber G
    Z Gesamte Inn Med; 1982 Dec; 37(24):849-53. PubMed ID: 7170822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Improving the bioavailability of digoxin.
    Binnion PF; Klopp RW
    Lancet; 1975 Jun; 1(7922):1422-3. PubMed ID: 49581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.